Kathi Durdon on Leadership and Innovation: Change is Good, Inevitable and Brings Discovery
Tuesday, August 16, 2016
The next step in Kathi Durdon's stewardship of the Upstate Biotech Accelerator comes Sept. 1.
That's when the accelerator opens two more floors. The aim is to put more researchers together in collaborative space, come up with new products, and move them quickly to the marketplace.
The accelerator, at 841 E. Fayette St., is a division of SUNY Upstate Medical University. It had a slow start. Steel beams went up, and then a funding freeze meant not much happened. By 2013, the building had opened with seven labs for scientists, technicians and entrepreneurs. Phase 2 construction started last year to build out the remaining space in the building.
Durdon was recruited a year ago from Welch-Allyn, where she had been manager of clinical affairs, to become director of operations.
"We're a relatively small center, and we specifically target biotech innovation," Durdon said. "That's good – we can quickly accommodate change. We provide low-cost licensed lab or office space, resources and services for biotech startups."